News > Covaxin emergency use: WHO seeks ‘additional clarifications’ from Bharat Biotech
Covaxin emergency use: WHO seeks ‘additional clarifications’ from Bharat Biotech
Scroll | 27/10/2021 08:45 AM | Click to read full article
The World Health Organization’s technical advisory group on Tuesday sought “additional clarifications” from India’s Bharat Biotech to conduct a final risk-benefit assessment for an emergency use listing of Covaxin.
The group will meet again on November 3 to consider the company’s request for an emergency listing if they receive data soon.
